Dow Stock Lands Bull Note Ahead of Earnings

Analysts are leaning bullish toward the drug name

Managing Editor
Oct 15, 2018 at 10:50 AM
facebook twitter linkedin


Shares of Johnson & Johnson (NYSE:JNJ) are modestly higher in mid-morning trading, the Dow name seeing a slight lift from an early morning price-target hike to $154 from $150 at BMO. Plus, traders are gearing up for the drug giant's third-quarter report, which is scheduled to surface before the market opens, tomorrow, Oct. 16. At last check, JNJ is up 0.9%, at $135.04.

On the charts, Johnson & Johnson stock surged to a record high of $148.3 back in January, but quickly gave back those gains and in late May fell to an annual low of $118.62. As of late, the shares have slightly recovered, and have now fallen in line with a 50% Fibonacci retracement of the stock's January high and mid-year low. From a broader perspective, the blue chip name remains a few points below breakeven year-to-date.

Daily Chart of JNJ with Fib Levels

Digging into its earnings history, JNJ closed lower the day after reporting in five of the last eight quarters, but did manage a 3.5% swing higher after its mid-July report. Looking broader, the shares have averaged a 2.7% move the day after earnings over the last two years, regardless of direction. This time around, JNJ options are pricing in a larger-than-usual 4% swing for Tuesday's trading.

Meanwhile, data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), shows JNJ sporting a 10-day call/put volume ratio of 2.65, which ranks in the 80th percentile of its annual range. In other words, calls have been purchased over puts at a faster-than-usual clip during the past two weeks of trading.

As per analyst sentiment, a majority of those following the security have "buy" or better ratings. What's more, the stock's average 12-month price target of $144.32 comes in at a 7% premium to current levels.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners